// App-Quantinova.ai

AB0456 (2021) : HYDROXYCHLOROQUINE MIGHT REDUCE MORTALITY IN PATIENTS WITH SYSTEMIC SCLEROSIS

Researchers

Presenter

  • M. Ozmen

Principal Investigators

  • E. Otman Akat

  • S. Gucenmez

  • G. Kabadayi

  • E. Durak Ediboglu

  • H. Cinakli

  • E. Erpek

  • I. Kurut Aysin

  • O. Bayindir

  • D. Solmaz

  • S. Akar

Medical Centers

  • qIzmir Katip Celebi University Faculty of Medicine, Izmir, Turkey

Locations

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Scleroderma

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved